Polyrizon partners with Clearmind to develop intranasal MEAI formulation
Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation| (NASDAQ: CMND) | Delayed: 1.67 +0.03 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.64 | 52 Week High | $ | |||
| Open | $1.67 | 52 Week Low | $ | |||
| Day High | $1.69 | P/E | N/A | |||
| Day Low | $1.61 | EPS | $ | |||
| Volume | 45,755 | |||||
| (NASDAQ: PLRZ) | Delayed: 14.39 +0.90 (6.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.49 | 52 Week High | $ | |||
| Open | $13.71 | 52 Week Low | $ | |||
| Day High | $14.73 | P/E | N/A | |||
| Day Low | $13.40 | EPS | $ | |||
| Volume | 81,295 | |||||

